Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study
- PMID: 22930295
- PMCID: PMC3576843
- DOI: 10.1258/ijsa.2012.011322
Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study
Abstract
We examined associations between stimulant use (methamphetamine and cocaine) and other substances (nicotine, marijuana, alcohol and inhaled nitrites) with immune function biomarkers among HIV-seropositive (HIV +) men taking highly active antiretroviral therapy (ART) and HIV-seronegative (HIV-) men in the Multicenter AIDS Cohort Study. Among HIV + men, cumulative adherence to ART (4.07, 95% confidence interval [CI]: 3.52, 4.71, per 10 years of adherent ART use), and recent cohort enrolment (1.38; 95% CI: 1.24, 1.55) were multiplicatively associated with increase in CD4+/CD8+ ratios. Cumulative use of methamphetamine (0.93; 95% CI: 0.88, 0.98, per 10 use-years), cocaine (0.93; 95% CI: 0.89, 0.96, per 10 use-years) and cumulative medical visits (0.99; 95% CI: 0.98, 0.99, per 10 visit-years), each showed small negative associations with CD4+/CD8+ ratios. Among HIV- men, cumulative medical visits (0.996; 95% CI: 0.993, 0.999), cumulative number of male sexual partners (0.999; 95% CI: 0.998, 0.9998, per 10 partner-years) and cigarette pack-years (1.10; 95% CI: 1.02, 1.18, per 10 pack-years) were associated with CD4+/CD8+ ratios over the same period. ART adherence is associated with a positive immune function independent of stimulant use, underscoring the influence of ART on immune health for HIV+ men who engage in stimulant use.
Conflict of interest statement
There are no financial conflicts of interest related to this research work.
References
-
- House R, Thomas P. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol. 1994;16:1–22. - PubMed
-
- Chiapelli F, Frost P, Manfrini E, Lee P, Pham L, Garcia C, et al. Cocaine blunts human CD4+ cell activation. Immunopharmacology. 1994;28:233–40. - PubMed
-
- Roth M, Rashkin D, Choi R, Jamieson B, Zack J, Baldwin G. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis. 2002;185:701–5. - PubMed
-
- Bagasra O, Pomerantz R. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis. 1993;168:1157–64. - PubMed
-
- Vittinghoff E, Hessol N, Bacchetti P, et al. Cofactors for HIV disease progression in a cohort of homosexual and bisexual men. J Acqui Immune Defic Syndr. 2001;27(3):308–314. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- 1R01DA022936/DA/NIDA NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R01 DA022936/DA/NIDA NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- U01 DA017394/DA/NIDA NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- 5U01DA017394-05/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
